Autologous cytokine-induced killer cells
Term · Oncology and biomedicine · MLC-T-ONC-011591
A proprietary formulation of autologous cytokine-induced killer (CIK) T lymphocytes, with immunopotentiating and antineoplastic activities. These CIK cells are generated by ex vivo incubation of autologous peripheral blood lymphocytes with an undisclosed mixture of compounds to stimulate killer T-cell differentiation; this is followed by expansion of the cells. Upon reintroduction into the patient, the autologous CIK cells are able to target and kill tumor cells.
| Identifier | MLC-T-ONC-011591 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011591",
"term": "Autologous cytokine-induced killer cells",
"field": "Oncology and biomedicine",
"definition": "A proprietary formulation of autologous cytokine-induced killer (CIK) T lymphocytes, with immunopotentiating and antineoplastic activities. These CIK cells are generated by ex vivo incubation of autologous peripheral blood lymphocytes with an undisclosed mixture of compounds to stimulate killer T-cell differentiation; this is followed by expansion of the cells. Upon reintroduction into the patient, the autologous CIK cells are able to target and kill tumor cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-cytokine-induced-killer-cells/"
}
Record 2,925 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.